Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) Depreciation & Amortization - Total (2018 - 2025)

Sanara MedTech (SMTI) has disclosed Depreciation & Amortization - Total for 8 consecutive years, with $41557.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Depreciation & Amortization - Total fell 67.93% year-over-year to $41557.0, compared with a TTM value of $768790.0 through Sep 2025, up 48.06%, and an annual FY2024 reading of $1.0 million, up 126.13% over the prior year.
  • Depreciation & Amortization - Total was $41557.0 for Q3 2025 at Sanara MedTech, down from $45350.0 in the prior quarter.
  • Across five years, Depreciation & Amortization - Total topped out at $635625.0 in Q4 2024 and bottomed at $17488.0 in Q1 2021.
  • Average Depreciation & Amortization - Total over 5 years is $118375.3, with a median of $106347.0 recorded in 2022.
  • The sharpest move saw Depreciation & Amortization - Total skyrocketed 478.76% in 2022, then tumbled 67.93% in 2025.
  • Year by year, Depreciation & Amortization - Total stood at $93123.0 in 2021, then rose by 15.02% to $107114.0 in 2022, then increased by 15.18% to $123376.0 in 2023, then soared by 415.19% to $635625.0 in 2024, then plummeted by 93.46% to $41557.0 in 2025.
  • Business Quant data shows Depreciation & Amortization - Total for SMTI at $41557.0 in Q3 2025, $45350.0 in Q2 2025, and $46258.0 in Q1 2025.